ABOS - Acumen Pharmaceuticals GAAP EPS of -$5.02 misses by $1.56 March, 28 2022 04:14 PM Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals press release (NASDAQ:ABOS): FY GAAP EPS of -$5.02 misses by $1.56. FY Cash and cash equivalents of $122.16M For further details see: Acumen Pharmaceuticals GAAP EPS of -$5.02 misses by $1.56